Due to the COVID-19 pandemic, the global Sofosbuvir (CAS 1190307-88-0) market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period.

Fully considering the economic change by this health crisis, Purity ≥ 98% accounting for % of the Sofosbuvir (CAS 1190307-88-0) global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Adults Patients segment is altered to an % CAGR throughout this forecast period.

China Sofosbuvir (CAS 1190307-88-0) market size is valued at US$ million in 2021, while the US and Europe Sofosbuvir (CAS 1190307-88-0) are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period.

As for the Europe Sofosbuvir (CAS 1190307-88-0) landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

The global key manufacturers of Sofosbuvir (CAS 1190307-88-0) include Teva Pharmaceutical Industries Ltd, DONG BANG FUTURE TECH & LIFE CO., LTD, Beaukev Pharma International Pvt.Ltd, DEAFARMA, Tecoland, Anhui HaiKang Pharmaceutical Co. Ltd, Shanghai Haoyuan Chemexpress Co., Ltd, Beijing Kawin Technology Share-holding Co and Hangzhou Longshine Bio-Tech Co. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

In terms of production side, this report researches the Sofosbuvir (CAS 1190307-88-0) capacity, production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.

In terms of sales side, this report focuses on the sales of Sofosbuvir (CAS 1190307-88-0) by region (region level and country level), by company, by Type and by Application. from 2017 to 2022 and forecast to 2028.

Global Sofosbuvir (CAS 1190307-88-0) Scope and Segment

Sofosbuvir (CAS 1190307-88-0) market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Sofosbuvir (CAS 1190307-88-0) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Purity ≥ 98%

Purity ＜ 98%

Segment by Application

Adults Patients

Elderly Patients

BY COMPANY

Teva Pharmaceutical Industries Ltd

DONG BANG FUTURE TECH & LIFE CO., LTD

Beaukev Pharma International Pvt.Ltd

DEAFARMA

Tecoland

Anhui HaiKang Pharmaceutical Co. Ltd

Shanghai Haoyuan Chemexpress Co., Ltd

Beijing Kawin Technology Share-holding Co

Hangzhou Longshine Bio-Tech Co

Production by Region

North America

Europe

China

Japan

Consumption by Region

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

U.A.E

FEATURED COMPANIES

Teva Pharmaceutical Industries Ltd

DONG BANG FUTURE TECH & LIFE CO., LTD

Beaukev Pharma International Pvt.Ltd

DEAFARMA

Tecoland

Anhui HaiKang Pharmaceutical Co. Ltd

Shanghai Haoyuan Chemexpress Co., Ltd

Beijing Kawin Technology Share-holding Co

Hangzhou Longshine Bio-Tech Co

1 Study Coverage

1.1 Sofosbuvir (CAS 1190307-88-0) Product Introduction

1.2 Market by Type

1.2.1 Global Sofosbuvir (CAS 1190307-88-0) Market Size by Type, 2017 VS 2021 VS 2028

1.2.2 Purity ≥ 98%

1.2.3 Purity ＜ 98%

1.3 Market by Application

1.3.1 Global Sofosbuvir (CAS 1190307-88-0) Market Size by Application, 2017 VS 2021 VS 2028

1.3.2 Adults Patients

1.3.3 Elderly Patients

1.4 Study Objectives

1.5 Years Considered

2 Global Sofosbuvir (CAS 1190307-88-0) Production

2.1 Global Sofosbuvir (CAS 1190307-88-0) Production Capacity (2017-2028)

2.2 Global Sofosbuvir (CAS 1190307-88-0) Production by Region: 2017 VS 2021 VS 2028

2.3 Global Sofosbuvir (CAS 1190307-88-0) Production by Region

2.3.1 Global Sofosbuvir (CAS 1190307-88-0) Historic Production by Region (2017-2022)

2.3.2 Global Sofosbuvir (CAS 1190307-88-0) Forecasted Production by Region (2023-2028)

2.4 North America

2.5 Europe

2.6 China

2.7 Japan

3 Global Sofosbuvir (CAS 1190307-88-0) Sales in Volume & Value Estimates and Forecasts

3.1 Global Sofosbuvir (CAS 1190307-88-0) Sales Estimates and Forecasts 2017-2028

3.2 Global Sofosbuvir (CAS 1190307-88-0) Revenue Estimates and Forecasts 2017-2028

3.3 Global Sofosbuvir (CAS 1190307-88-0) Revenue by Region: 2017 VS 2021 VS 2028

3.4 Global Sofosbuvir (CAS 1190307-88-0) Sales by Region

3.4.1 Global Sofosbuvir (CAS 1190307-88-0) Sales by Region (2017-2022)

3.4.2 Global Sales Sofosbuvir (CAS 1190307-88-0) by Region (2023-2028)

3.5 Global Sofosbuvir (CAS 1190307-88-0) Revenue by Region

3.5.1 Global Sofosbuvir (CAS 1190307-88-0) Revenue by Region (2017-2022)

3.5.2 Global Sofosbuvir (CAS 1190307-88-0) Revenue by Region (2023-2028)

3.6 North America

3.7 Europe

3.8 Asia-Pacific

3.9 Latin America

3.10 Middle East & Africa

4 Competition by Manufactures

4.1 Global Sofosbuvir (CAS 1190307-88-0) Production Capacity by Manufacturers

4.2 Global Sofosbuvir (CAS 1190307-88-0) Sales by Manufacturers

4.2.1 Global Sofosbuvir (CAS 1190307-88-0) Sales by Manufacturers (2017-2022)

4.2.2 Global Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Manufacturers (2017-2022)

4.2.3 Global Top 10 and Top 5 Largest Manufacturers of Sofosbuvir (CAS 1190307-88-0) in 2021

4.3 Global Sofosbuvir (CAS 1190307-88-0) Revenue by Manufacturers

4.3.1 Global Sofosbuvir (CAS 1190307-88-0) Revenue by Manufacturers (2017-2022)

4.3.2 Global Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Manufacturers (2017-2022)

4.3.3 Global Top 10 and Top 5 Companies by Sofosbuvir (CAS 1190307-88-0) Revenue in 2021

4.4 Global Sofosbuvir (CAS 1190307-88-0) Sales Price by Manufacturers

4.5 Analysis of Competitive Landscape

4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

4.5.2 Global Sofosbuvir (CAS 1190307-88-0) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

4.5.3 Global Sofosbuvir (CAS 1190307-88-0) Manufacturers Geographical Distribution

4.6 Mergers & Acquisitions, Expansion Plans

5 Market Size by Type

5.1 Global Sofosbuvir (CAS 1190307-88-0) Sales by Type

5.1.1 Global Sofosbuvir (CAS 1190307-88-0) Historical Sales by Type (2017-2022)

5.1.2 Global Sofosbuvir (CAS 1190307-88-0) Forecasted Sales by Type (2023-2028)

5.1.3 Global Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Type (2017-2028)

5.2 Global Sofosbuvir (CAS 1190307-88-0) Revenue by Type

5.2.1 Global Sofosbuvir (CAS 1190307-88-0) Historical Revenue by Type (2017-2022)

5.2.2 Global Sofosbuvir (CAS 1190307-88-0) Forecasted Revenue by Type (2023-2028)

5.2.3 Global Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Type (2017-2028)

5.3 Global Sofosbuvir (CAS 1190307-88-0) Price by Type

5.3.1 Global Sofosbuvir (CAS 1190307-88-0) Price by Type (2017-2022)

5.3.2 Global Sofosbuvir (CAS 1190307-88-0) Price Forecast by Type (2023-2028)

6 Market Size by Application

6.1 Global Sofosbuvir (CAS 1190307-88-0) Sales by Application

6.1.1 Global Sofosbuvir (CAS 1190307-88-0) Historical Sales by Application (2017-2022)

6.1.2 Global Sofosbuvir (CAS 1190307-88-0) Forecasted Sales by Application (2023-2028)

6.1.3 Global Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Application (2017-2028)

6.2 Global Sofosbuvir (CAS 1190307-88-0) Revenue by Application

6.2.1 Global Sofosbuvir (CAS 1190307-88-0) Historical Revenue by Application (2017-2022)

6.2.2 Global Sofosbuvir (CAS 1190307-88-0) Forecasted Revenue by Application (2023-2028)

6.2.3 Global Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Application (2017-2028)

6.3 Global Sofosbuvir (CAS 1190307-88-0) Price by Application

6.3.1 Global Sofosbuvir (CAS 1190307-88-0) Price by Application (2017-2022)

6.3.2 Global Sofosbuvir (CAS 1190307-88-0) Price Forecast by Application (2023-2028)

7 North America

7.1 North America Sofosbuvir (CAS 1190307-88-0) Market Size by Type

7.1.1 North America Sofosbuvir (CAS 1190307-88-0) Sales by Type (2017-2028)

7.1.2 North America Sofosbuvir (CAS 1190307-88-0) Revenue by Type (2017-2028)

7.2 North America Sofosbuvir (CAS 1190307-88-0) Market Size by Application

7.2.1 North America Sofosbuvir (CAS 1190307-88-0) Sales by Application (2017-2028)

7.2.2 North America Sofosbuvir (CAS 1190307-88-0) Revenue by Application (2017-2028)

7.3 North America Sofosbuvir (CAS 1190307-88-0) Sales by Country

7.3.1 North America Sofosbuvir (CAS 1190307-88-0) Sales by Country (2017-2028)

7.3.2 North America Sofosbuvir (CAS 1190307-88-0) Revenue by Country (2017-2028)

7.3.3 U.S.

7.3.4 Canada

8 Europe

8.1 Europe Sofosbuvir (CAS 1190307-88-0) Market Size by Type

8.1.1 Europe Sofosbuvir (CAS 1190307-88-0) Sales by Type (2017-2028)

8.1.2 Europe Sofosbuvir (CAS 1190307-88-0) Revenue by Type (2017-2028)

8.2 Europe Sofosbuvir (CAS 1190307-88-0) Market Size by Application

8.2.1 Europe Sofosbuvir (CAS 1190307-88-0) Sales by Application (2017-2028)

8.2.2 Europe Sofosbuvir (CAS 1190307-88-0) Revenue by Application (2017-2028)

8.3 Europe Sofosbuvir (CAS 1190307-88-0) Sales by Country

8.3.1 Europe Sofosbuvir (CAS 1190307-88-0) Sales by Country (2017-2028)

8.3.2 Europe Sofosbuvir (CAS 1190307-88-0) Revenue by Country (2017-2028)

8.3.3 Germany

8.3.4 France

8.3.5 U.K.

8.3.6 Italy

8.3.7 Russia

9 Asia Pacific

9.1 Asia Pacific Sofosbuvir (CAS 1190307-88-0) Market Size by Type

9.1.1 Asia Pacific Sofosbuvir (CAS 1190307-88-0) Sales by Type (2017-2028)

9.1.2 Asia Pacific Sofosbuvir (CAS 1190307-88-0) Revenue by Type (2017-2028)

9.2 Asia Pacific Sofosbuvir (CAS 1190307-88-0) Market Size by Application

9.2.1 Asia Pacific Sofosbuvir (CAS 1190307-88-0) Sales by Application (2017-2028)

9.2.2 Asia Pacific Sofosbuvir (CAS 1190307-88-0) Revenue by Application (2017-2028)

9.3 Asia Pacific Sofosbuvir (CAS 1190307-88-0) Sales by Region

9.3.1 Asia Pacific Sofosbuvir (CAS 1190307-88-0) Sales by Region (2017-2028)

9.3.2 Asia Pacific Sofosbuvir (CAS 1190307-88-0) Revenue by Region (2017-2028)

9.3.3 China

9.3.4 Japan

9.3.5 South Korea

9.3.6 India

9.3.7 Australia

9.3.8 Taiwan

9.3.9 Indonesia

9.3.10 Thailand

9.3.11 Malaysia

9.3.12 Philippines

10 Latin America

10.1 Latin America Sofosbuvir (CAS 1190307-88-0) Market Size by Type

10.1.1 Latin America Sofosbuvir (CAS 1190307-88-0) Sales by Type (2017-2028)

10.1.2 Latin America Sofosbuvir (CAS 1190307-88-0) Revenue by Type (2017-2028)

10.2 Latin America Sofosbuvir (CAS 1190307-88-0) Market Size by Application

10.2.1 Latin America Sofosbuvir (CAS 1190307-88-0) Sales by Application (2017-2028)

10.2.2 Latin America Sofosbuvir (CAS 1190307-88-0) Revenue by Application (2017-2028)

10.3 Latin America Sofosbuvir (CAS 1190307-88-0) Sales by Country

10.3.1 Latin America Sofosbuvir (CAS 1190307-88-0) Sales by Country (2017-2028)

10.3.2 Latin America Sofosbuvir (CAS 1190307-88-0) Revenue by Country (2017-2028)

10.3.3 Mexico

10.3.4 Brazil

10.3.5 Argentina

11 Middle East and Africa

11.1 Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Market Size by Type

11.1.1 Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Sales by Type (2017-2028)

11.1.2 Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Revenue by Type (2017-2028)

11.2 Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Market Size by Application

11.2.1 Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Sales by Application (2017-2028)

11.2.2 Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Revenue by Application (2017-2028)

11.3 Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Sales by Country

11.3.1 Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Sales by Country (2017-2028)

11.3.2 Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Revenue by Country (2017-2028)

11.3.3 Turkey

11.3.4 Saudi Arabia

11.3.5 U.A.E

12 Corporate Profiles

12.1 Teva Pharmaceutical Industries Ltd

12.1.1 Teva Pharmaceutical Industries Ltd Corporation Information

12.1.2 Teva Pharmaceutical Industries Ltd Overview

12.1.3 Teva Pharmaceutical Industries Ltd Sofosbuvir (CAS 1190307-88-0) Sales, Price, Revenue and Gross Margin (2017-2022)

12.1.4 Teva Pharmaceutical Industries Ltd Sofosbuvir (CAS 1190307-88-0) Product Model Numbers, Pictures, Descriptions and Specifications

12.1.5 Teva Pharmaceutical Industries Ltd Recent Developments

12.2 DONG BANG FUTURE TECH & LIFE CO., LTD

12.2.1 DONG BANG FUTURE TECH & LIFE CO., LTD Corporation Information

12.2.2 DONG BANG FUTURE TECH & LIFE CO., LTD Overview

12.2.3 DONG BANG FUTURE TECH & LIFE CO., LTD Sofosbuvir (CAS 1190307-88-0) Sales, Price, Revenue and Gross Margin (2017-2022)

12.2.4 DONG BANG FUTURE TECH & LIFE CO., LTD Sofosbuvir (CAS 1190307-88-0) Product Model Numbers, Pictures, Descriptions and Specifications

12.2.5 DONG BANG FUTURE TECH & LIFE CO., LTD Recent Developments

12.3 Beaukev Pharma International Pvt.Ltd

12.3.1 Beaukev Pharma International Pvt.Ltd Corporation Information

12.3.2 Beaukev Pharma International Pvt.Ltd Overview

12.3.3 Beaukev Pharma International Pvt.Ltd Sofosbuvir (CAS 1190307-88-0) Sales, Price, Revenue and Gross Margin (2017-2022)

12.3.4 Beaukev Pharma International Pvt.Ltd Sofosbuvir (CAS 1190307-88-0) Product Model Numbers, Pictures, Descriptions and Specifications

12.3.5 Beaukev Pharma International Pvt.Ltd Recent Developments

12.4 DEAFARMA

12.4.1 DEAFARMA Corporation Information

12.4.2 DEAFARMA Overview

12.4.3 DEAFARMA Sofosbuvir (CAS 1190307-88-0) Sales, Price, Revenue and Gross Margin (2017-2022)

12.4.4 DEAFARMA Sofosbuvir (CAS 1190307-88-0) Product Model Numbers, Pictures, Descriptions and Specifications

12.4.5 DEAFARMA Recent Developments

12.5 Tecoland

12.5.1 Tecoland Corporation Information

12.5.2 Tecoland Overview

12.5.3 Tecoland Sofosbuvir (CAS 1190307-88-0) Sales, Price, Revenue and Gross Margin (2017-2022)

12.5.4 Tecoland Sofosbuvir (CAS 1190307-88-0) Product Model Numbers, Pictures, Descriptions and Specifications

12.5.5 Tecoland Recent Developments

12.6 Anhui HaiKang Pharmaceutical Co. Ltd

12.6.1 Anhui HaiKang Pharmaceutical Co. Ltd Corporation Information

12.6.2 Anhui HaiKang Pharmaceutical Co. Ltd Overview

12.6.3 Anhui HaiKang Pharmaceutical Co. Ltd Sofosbuvir (CAS 1190307-88-0) Sales, Price, Revenue and Gross Margin (2017-2022)

12.6.4 Anhui HaiKang Pharmaceutical Co. Ltd Sofosbuvir (CAS 1190307-88-0) Product Model Numbers, Pictures, Descriptions and Specifications

12.6.5 Anhui HaiKang Pharmaceutical Co. Ltd Recent Developments

12.7 Shanghai Haoyuan Chemexpress Co., Ltd

12.7.1 Shanghai Haoyuan Chemexpress Co., Ltd Corporation Information

12.7.2 Shanghai Haoyuan Chemexpress Co., Ltd Overview

12.7.3 Shanghai Haoyuan Chemexpress Co., Ltd Sofosbuvir (CAS 1190307-88-0) Sales, Price, Revenue and Gross Margin (2017-2022)

12.7.4 Shanghai Haoyuan Chemexpress Co., Ltd Sofosbuvir (CAS 1190307-88-0) Product Model Numbers, Pictures, Descriptions and Specifications

12.7.5 Shanghai Haoyuan Chemexpress Co., Ltd Recent Developments

12.8 Beijing Kawin Technology Share-holding Co

12.8.1 Beijing Kawin Technology Share-holding Co Corporation Information

12.8.2 Beijing Kawin Technology Share-holding Co Overview

12.8.3 Beijing Kawin Technology Share-holding Co Sofosbuvir (CAS 1190307-88-0) Sales, Price, Revenue and Gross Margin (2017-2022)

12.8.4 Beijing Kawin Technology Share-holding Co Sofosbuvir (CAS 1190307-88-0) Product Model Numbers, Pictures, Descriptions and Specifications

12.8.5 Beijing Kawin Technology Share-holding Co Recent Developments

12.9 Hangzhou Longshine Bio-Tech Co

12.9.1 Hangzhou Longshine Bio-Tech Co Corporation Information

12.9.2 Hangzhou Longshine Bio-Tech Co Overview

12.9.3 Hangzhou Longshine Bio-Tech Co Sofosbuvir (CAS 1190307-88-0) Sales, Price, Revenue and Gross Margin (2017-2022)

12.9.4 Hangzhou Longshine Bio-Tech Co Sofosbuvir (CAS 1190307-88-0) Product Model Numbers, Pictures, Descriptions and Specifications

12.9.5 Hangzhou Longshine Bio-Tech Co Recent Developments

13 Industry Chain and Sales Channels Analysis

13.1 Sofosbuvir (CAS 1190307-88-0) Industry Chain Analysis

13.2 Sofosbuvir (CAS 1190307-88-0) Key Raw Materials

13.2.1 Key Raw Materials

13.2.2 Raw Materials Key Suppliers

13.3 Sofosbuvir (CAS 1190307-88-0) Production Mode & Process

13.4 Sofosbuvir (CAS 1190307-88-0) Sales and Marketing

13.4.1 Sofosbuvir (CAS 1190307-88-0) Sales Channels

13.4.2 Sofosbuvir (CAS 1190307-88-0) Distributors

13.5 Sofosbuvir (CAS 1190307-88-0) Customers

14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

14.1 Sofosbuvir (CAS 1190307-88-0) Industry Trends

14.2 Sofosbuvir (CAS 1190307-88-0) Market Drivers

14.3 Sofosbuvir (CAS 1190307-88-0) Market Challenges

14.4 Sofosbuvir (CAS 1190307-88-0) Market Restraints

15 Key Finding in The Global Sofosbuvir (CAS 1190307-88-0) Study

16 Appendix

16.1 Research Methodology

16.1.1 Methodology/Research Approach

16.1.2 Data Source

16.2 Author Details

16.3 Disclaimer

FEATURED COMPANIES

Teva Pharmaceutical Industries Ltd

DONG BANG FUTURE TECH & LIFE CO., LTD

Beaukev Pharma International Pvt.Ltd

DEAFARMA

Tecoland

Anhui HaiKang Pharmaceutical Co. Ltd

Shanghai Haoyuan Chemexpress Co., Ltd

Beijing Kawin Technology Share-holding Co

Hangzhou Longshine Bio-Tech Co

List of Tables

Table 1. Global Sofosbuvir (CAS 1190307-88-0) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)

Table 2. Major Manufacturers of Purity ≥ 98%

Table 3. Major Manufacturers of Purity ＜ 98%

Table 4. Global Sofosbuvir (CAS 1190307-88-0) Market Size Growth Rate by Application, 2017 VS 2021 2028 (US$ Million)

Table 5. Global Sofosbuvir (CAS 1190307-88-0) Production by Region: 2017 VS 2021 VS 2028 (MT)

Table 6. Global Sofosbuvir (CAS 1190307-88-0) Production by Region (2017-2022) & (MT)

Table 7. Global Sofosbuvir (CAS 1190307-88-0) Production Market Share by Region (2017-2022)

Table 8. Global Sofosbuvir (CAS 1190307-88-0) Production by Region (2023-2028) & (MT)

Table 9. Global Sofosbuvir (CAS 1190307-88-0) Production Market Share by Region (2023-2028)

Table 10. Global Sofosbuvir (CAS 1190307-88-0) Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)

Table 11. Global Sofosbuvir (CAS 1190307-88-0) Sales by Region (2017-2022) & (MT)

Table 12. Global Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Region (2017-2022)

Table 13. Global Sofosbuvir (CAS 1190307-88-0) Sales by Region (2023-2028) & (MT)

Table 14. Global Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Region (2023-2028)

Table 15. Global Sofosbuvir (CAS 1190307-88-0) Revenue by Region (2017-2022) & (US$ Million)

Table 16. Global Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Region (2017-2022)

Table 17. Global Sofosbuvir (CAS 1190307-88-0) Revenue by Region (2023-2028) & (US$ Million)

Table 18. Global Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Region (2023-2028)

Table 19. Global Sofosbuvir (CAS 1190307-88-0) Production Capacity by Manufacturers (2017-2022) & (MT)

Table 20. Global Sofosbuvir (CAS 1190307-88-0) Capacity Market Share by Manufacturers (2017-2022)

Table 21. Global Sofosbuvir (CAS 1190307-88-0) Sales by Manufacturers (2017-2022) & (MT)

Table 22. Global Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Manufacturers (2017-2022)

Table 23. Global Sofosbuvir (CAS 1190307-88-0) Revenue by Manufacturers (2017-2022) & (US$ Million)

Table 24. Global Sofosbuvir (CAS 1190307-88-0) Revenue Share by Manufacturers (2017-2022)

Table 25. Sofosbuvir (CAS 1190307-88-0) Price by Manufacturers 2017-2022 (USD/MT)

Table 26. Global Sofosbuvir (CAS 1190307-88-0) Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 27. Global Sofosbuvir (CAS 1190307-88-0) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sofosbuvir (CAS 1190307-88-0) as of 2021)

Table 28. Sofosbuvir (CAS 1190307-88-0) Manufacturing Base Distribution and Headquarters

Table 29. Manufacturers Sofosbuvir (CAS 1190307-88-0) Product Offered

Table 30. Date of Manufacturers Enter into Sofosbuvir (CAS 1190307-88-0) Market

Table 31. Mergers & Acquisitions, Expansion Plans

Table 32. Global Sofosbuvir (CAS 1190307-88-0) Sales by Type (2017-2022) & (MT)

Table 33. Global Sofosbuvir (CAS 1190307-88-0) Sales by Type (2023-2028) & (MT)

Table 34. Global Sofosbuvir (CAS 1190307-88-0) Sales Share by Type (2017-2022)

Table 35. Global Sofosbuvir (CAS 1190307-88-0) Sales Share by Type (2023-2028)

Table 36. Global Sofosbuvir (CAS 1190307-88-0) Revenue by Type (2017-2022) & (US$ Million)

Table 37. Global Sofosbuvir (CAS 1190307-88-0) Revenue by Type (2023-2028) & (US$ Million)

Table 38. Global Sofosbuvir (CAS 1190307-88-0) Revenue Share by Type (2017-2022)

Table 39. Global Sofosbuvir (CAS 1190307-88-0) Revenue Share by Type (2023-2028)

Table 40. Sofosbuvir (CAS 1190307-88-0) Price by Type (2017-2022) & (USD/MT)

Table 41. Global Sofosbuvir (CAS 1190307-88-0) Price Forecast by Type (2023-2028) & (USD/MT)

Table 42. Global Sofosbuvir (CAS 1190307-88-0) Sales by Application (2017-2022) & (MT)

Table 43. Global Sofosbuvir (CAS 1190307-88-0) Sales by Application (2023-2028) & (MT)

Table 44. Global Sofosbuvir (CAS 1190307-88-0) Sales Share by Application (2017-2022)

Table 45. Global Sofosbuvir (CAS 1190307-88-0) Sales Share by Application (2023-2028)

Table 46. Global Sofosbuvir (CAS 1190307-88-0) Revenue by Application (2017-2022) & (US$ Million)

Table 47. Global Sofosbuvir (CAS 1190307-88-0) Revenue by Application (2023-2028) & (US$ Million)

Table 48. Global Sofosbuvir (CAS 1190307-88-0) Revenue Share by Application (2017-2022)

Table 49. Global Sofosbuvir (CAS 1190307-88-0) Revenue Share by Application (2023-2028)

Table 50. Sofosbuvir (CAS 1190307-88-0) Price by Application (2017-2022) & (USD/MT)

Table 51. Global Sofosbuvir (CAS 1190307-88-0) Price Forecast by Application (2023-2028) & (USD/MT)

Table 52. North America Sofosbuvir (CAS 1190307-88-0) Sales by Type (2017-2022) & (MT)

Table 53. North America Sofosbuvir (CAS 1190307-88-0) Sales by Type (2023-2028) & (MT)

Table 54. North America Sofosbuvir (CAS 1190307-88-0) Revenue by Type (2017-2022) & (US$ Million)

Table 55. North America Sofosbuvir (CAS 1190307-88-0) Revenue by Type (2023-2028) & (US$ Million)

Table 56. North America Sofosbuvir (CAS 1190307-88-0) Sales by Application (2017-2022) & (MT)

Table 57. North America Sofosbuvir (CAS 1190307-88-0) Sales by Application (2023-2028) & (MT)

Table 58. North America Sofosbuvir (CAS 1190307-88-0) Revenue by Application (2017-2022) & (US$ Million)

Table 59. North America Sofosbuvir (CAS 1190307-88-0) Revenue by Application (2023-2028) & (US$ Million)

Table 60. North America Sofosbuvir (CAS 1190307-88-0) Sales by Country (2017-2022) & (MT)

Table 61. North America Sofosbuvir (CAS 1190307-88-0) Sales by Country (2023-2028) & (MT)

Table 62. North America Sofosbuvir (CAS 1190307-88-0) Revenue by Country (2017-2022) & (US$ Million)

Table 63. North America Sofosbuvir (CAS 1190307-88-0) Revenue by Country (2023-2028) & (US$ Million)

Table 64. Europe Sofosbuvir (CAS 1190307-88-0) Sales by Type (2017-2022) & (MT)

Table 65. Europe Sofosbuvir (CAS 1190307-88-0) Sales by Type (2023-2028) & (MT)

Table 66. Europe Sofosbuvir (CAS 1190307-88-0) Revenue by Type (2017-2022) & (US$ Million)

Table 67. Europe Sofosbuvir (CAS 1190307-88-0) Revenue by Type (2023-2028) & (US$ Million)

Table 68. Europe Sofosbuvir (CAS 1190307-88-0) Sales by Application (2017-2022) & (MT)

Table 69. Europe Sofosbuvir (CAS 1190307-88-0) Sales by Application (2023-2028) & (MT)

Table 70. Europe Sofosbuvir (CAS 1190307-88-0) Revenue by Application (2017-2022) & (US$ Million)

Table 71. Europe Sofosbuvir (CAS 1190307-88-0) Revenue by Application (2023-2028) & (US$ Million)

Table 72. Europe Sofosbuvir (CAS 1190307-88-0) Sales by Country (2017-2022) & (MT)

Table 73. Europe Sofosbuvir (CAS 1190307-88-0) Sales by Country (2023-2028) & (MT)

Table 74. Europe Sofosbuvir (CAS 1190307-88-0) Revenue by Country (2017-2022) & (US$ Million)

Table 75. Europe Sofosbuvir (CAS 1190307-88-0) Revenue by Country (2023-2028) & (US$ Million)

Table 76. Asia Pacific Sofosbuvir (CAS 1190307-88-0) Sales by Type (2017-2022) & (MT)

Table 77. Asia Pacific Sofosbuvir (CAS 1190307-88-0) Sales by Type (2023-2028) & (MT)

Table 78. Asia Pacific Sofosbuvir (CAS 1190307-88-0) Revenue by Type (2017-2022) & (US$ Million)

Table 79. Asia Pacific Sofosbuvir (CAS 1190307-88-0) Revenue by Type (2023-2028) & (US$ Million)

Table 80. Asia Pacific Sofosbuvir (CAS 1190307-88-0) Sales by Application (2017-2022) & (MT)

Table 81. Asia Pacific Sofosbuvir (CAS 1190307-88-0) Sales by Application (2023-2028) & (MT)

Table 82. Asia Pacific Sofosbuvir (CAS 1190307-88-0) Revenue by Application (2017-2022) & (US$ Million)

Table 83. Asia Pacific Sofosbuvir (CAS 1190307-88-0) Revenue by Application (2023-2028) & (US$ Million)

Table 84. Asia Pacific Sofosbuvir (CAS 1190307-88-0) Sales by Region (2017-2022) & (MT)

Table 85. Asia Pacific Sofosbuvir (CAS 1190307-88-0) Sales by Region (2023-2028) & (MT)

Table 86. Asia Pacific Sofosbuvir (CAS 1190307-88-0) Revenue by Region (2017-2022) & (US$ Million)

Table 87. Asia Pacific Sofosbuvir (CAS 1190307-88-0) Revenue by Region (2023-2028) & (US$ Million)

Table 88. Latin America Sofosbuvir (CAS 1190307-88-0) Sales by Type (2017-2022) & (MT)

Table 89. Latin America Sofosbuvir (CAS 1190307-88-0) Sales by Type (2023-2028) & (MT)

Table 90. Latin America Sofosbuvir (CAS 1190307-88-0) Revenue by Type (2017-2022) & (US$ Million)

Table 91. Latin America Sofosbuvir (CAS 1190307-88-0) Revenue by Type (2023-2028) & (US$ Million)

Table 92. Latin America Sofosbuvir (CAS 1190307-88-0) Sales by Application (2017-2022) & (MT)

Table 93. Latin America Sofosbuvir (CAS 1190307-88-0) Sales by Application (2023-2028) & (MT)

Table 94. Latin America Sofosbuvir (CAS 1190307-88-0) Revenue by Application (2017-2022) & (US$ Million)

Table 95. Latin America Sofosbuvir (CAS 1190307-88-0) Revenue by Application (2023-2028) & (US$ Million)

Table 96. Latin America Sofosbuvir (CAS 1190307-88-0) Sales by Country (2017-2022) & (MT)

Table 97. Latin America Sofosbuvir (CAS 1190307-88-0) Sales by Country (2023-2028) & (MT)

Table 98. Latin America Sofosbuvir (CAS 1190307-88-0) Revenue by Country (2017-2022) & (US$ Million)

Table 99. Latin America Sofosbuvir (CAS 1190307-88-0) Revenue by Country (2023-2028) & (US$ Million)

Table 100. Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Sales by Type (2017-2022) & (MT)

Table 101. Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Sales by Type (2023-2028) & (MT)

Table 102. Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Revenue by Type (2017-2022) & (US$ Million)

Table 103. Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Revenue by Type (2023-2028) & (US$ Million)

Table 104. Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Sales by Application (2017-2022) & (MT)

Table 105. Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Sales by Application (2023-2028) & (MT)

Table 106. Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Revenue by Application (2017-2022) & (US$ Million)

Table 107. Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Revenue by Application (2023-2028) & (US$ Million)

Table 108. Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Sales by Country (2017-2022) & (MT)

Table 109. Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Sales by Country (2023-2028) & (MT)

Table 110. Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Revenue by Country (2017-2022) & (US$ Million)

Table 111. Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Revenue by Country (2023-2028) & (US$ Million)

Table 112. Teva Pharmaceutical Industries Ltd Corporation Information

Table 113. Teva Pharmaceutical Industries Ltd Description and Major Businesses

Table 114. Teva Pharmaceutical Industries Ltd Sofosbuvir (CAS 1190307-88-0) Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)

Table 115. Teva Pharmaceutical Industries Ltd Sofosbuvir (CAS 1190307-88-0) Product Model Numbers, Pictures, Descriptions and Specifications

Table 116. Teva Pharmaceutical Industries Ltd Recent Development

Table 117. DONG BANG FUTURE TECH & LIFE CO., LTD Corporation Information

Table 118. DONG BANG FUTURE TECH & LIFE CO., LTD Description and Major Businesses

Table 119. DONG BANG FUTURE TECH & LIFE CO., LTD Sofosbuvir (CAS 1190307-88-0) Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)

Table 120. DONG BANG FUTURE TECH & LIFE CO., LTD Sofosbuvir (CAS 1190307-88-0) Product Model Numbers, Pictures, Descriptions and Specifications

Table 121. DONG BANG FUTURE TECH & LIFE CO., LTD Recent Development

Table 122. Beaukev Pharma International Pvt.Ltd Corporation Information

Table 123. Beaukev Pharma International Pvt.Ltd Description and Major Businesses

Table 124. Beaukev Pharma International Pvt.Ltd Sofosbuvir (CAS 1190307-88-0) Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)

Table 125. Beaukev Pharma International Pvt.Ltd Sofosbuvir (CAS 1190307-88-0) Product Model Numbers, Pictures, Descriptions and Specifications

Table 126. Beaukev Pharma International Pvt.Ltd Recent Development

Table 127. DEAFARMA Corporation Information

Table 128. DEAFARMA Description and Major Businesses

Table 129. DEAFARMA Sofosbuvir (CAS 1190307-88-0) Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)

Table 130. DEAFARMA Sofosbuvir (CAS 1190307-88-0) Product Model Numbers, Pictures, Descriptions and Specifications

Table 131. DEAFARMA Recent Development

Table 132. Tecoland Corporation Information

Table 133. Tecoland Description and Major Businesses

Table 134. Tecoland Sofosbuvir (CAS 1190307-88-0) Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)

Table 135. Tecoland Sofosbuvir (CAS 1190307-88-0) Product Model Numbers, Pictures, Descriptions and Specifications

Table 136. Tecoland Recent Development

Table 137. Anhui HaiKang Pharmaceutical Co. Ltd Corporation Information

Table 138. Anhui HaiKang Pharmaceutical Co. Ltd Description and Major Businesses

Table 139. Anhui HaiKang Pharmaceutical Co. Ltd Sofosbuvir (CAS 1190307-88-0) Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)

Table 140. Anhui HaiKang Pharmaceutical Co. Ltd Sofosbuvir (CAS 1190307-88-0) Product Model Numbers, Pictures, Descriptions and Specifications

Table 141. Anhui HaiKang Pharmaceutical Co. Ltd Recent Development

Table 142. Shanghai Haoyuan Chemexpress Co., Ltd Corporation Information

Table 143. Shanghai Haoyuan Chemexpress Co., Ltd Description and Major Businesses

Table 144. Shanghai Haoyuan Chemexpress Co., Ltd Sofosbuvir (CAS 1190307-88-0) Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)

Table 145. Shanghai Haoyuan Chemexpress Co., Ltd Sofosbuvir (CAS 1190307-88-0) Product Model Numbers, Pictures, Descriptions and Specifications

Table 146. Shanghai Haoyuan Chemexpress Co., Ltd Recent Development

Table 147. Beijing Kawin Technology Share-holding Co Corporation Information

Table 148. Beijing Kawin Technology Share-holding Co Description and Major Businesses

Table 149. Beijing Kawin Technology Share-holding Co Sofosbuvir (CAS 1190307-88-0) Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)

Table 150. Beijing Kawin Technology Share-holding Co Sofosbuvir (CAS 1190307-88-0) Product Model Numbers, Pictures, Descriptions and Specifications

Table 151. Beijing Kawin Technology Share-holding Co Recent Development

Table 152. Hangzhou Longshine Bio-Tech Co Corporation Information

Table 153. Hangzhou Longshine Bio-Tech Co Description and Major Businesses

Table 154. Hangzhou Longshine Bio-Tech Co Sofosbuvir (CAS 1190307-88-0) Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)

Table 155. Hangzhou Longshine Bio-Tech Co Sofosbuvir (CAS 1190307-88-0) Product Model Numbers, Pictures, Descriptions and Specifications

Table 156. Hangzhou Longshine Bio-Tech Co Recent Development

Table 157. Key Raw Materials Lists

Table 158. Raw Materials Key Suppliers Lists

Table 159. Sofosbuvir (CAS 1190307-88-0) Distributors List

Table 160. Sofosbuvir (CAS 1190307-88-0) Customers List

Table 161. Sofosbuvir (CAS 1190307-88-0) Market Trends

Table 162. Sofosbuvir (CAS 1190307-88-0) Market Drivers

Table 163. Sofosbuvir (CAS 1190307-88-0) Market Challenges

Table 164. Sofosbuvir (CAS 1190307-88-0) Market Restraints

Table 165. Research Programs/Design for This Report

Table 166. Key Data Information from Secondary Sources

Table 167. Key Data Information from Primary Sources

List of Figures

Figure 1. Sofosbuvir (CAS 1190307-88-0) Product Picture

Figure 2. Global Sofosbuvir (CAS 1190307-88-0) Market Share by Type in 2021 & 2028

Figure 3. Purity ≥ 98% Product Picture

Figure 4. Purity ＜ 98% Product Picture

Figure 5. Global Sofosbuvir (CAS 1190307-88-0) Market Share by Application in 2021 & 2028

Figure 6. Adults Patients

Figure 7. Elderly Patients

Figure 8. Sofosbuvir (CAS 1190307-88-0) Report Years Considered

Figure 9. Global Sofosbuvir (CAS 1190307-88-0) Capacity, Production and Utilization (2017-2028) & (MT)

Figure 10. Global Sofosbuvir (CAS 1190307-88-0) Production Market Share by Region in Percentage: 2021 Versus 2028

Figure 11. Global Sofosbuvir (CAS 1190307-88-0) Production Market Share by Region (2017-2022)

Figure 12. Global Sofosbuvir (CAS 1190307-88-0) Production Market Share by Region (2023-2028)

Figure 13. Sofosbuvir (CAS 1190307-88-0) Production Growth Rate in North America (2017-2028) & (MT)

Figure 14. Sofosbuvir (CAS 1190307-88-0) Production Growth Rate in Europe (2017-2028) & (MT)

Figure 15. Sofosbuvir (CAS 1190307-88-0) Production Growth Rate in China (2017-2028) & (MT)

Figure 16. Sofosbuvir (CAS 1190307-88-0) Production Growth Rate in Japan (2017-2028) & (MT)

Figure 17. Global Sofosbuvir (CAS 1190307-88-0) Sales 2017-2028 (MT)

Figure 18. Global Sofosbuvir (CAS 1190307-88-0) Revenue, (US$ Million), 2017 VS 2021 VS 2028

Figure 19. Global Sofosbuvir (CAS 1190307-88-0) Revenue 2017-2028 (US$ Million)

Figure 20. Global Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Region in Percentage: 2021 Versus 2028

Figure 21. Global Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Region (2017-2022)

Figure 22. Global Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Region (2023-2028)

Figure 23. North America Sofosbuvir (CAS 1190307-88-0) Sales YoY (2017-2028) & (MT)

Figure 24. North America Sofosbuvir (CAS 1190307-88-0) Revenue YoY (2017-2028) & (US$ Million)

Figure 25. Europe Sofosbuvir (CAS 1190307-88-0) Sales YoY (2017-2028) & (MT)

Figure 26. Europe Sofosbuvir (CAS 1190307-88-0) Revenue YoY (2017-2028) & (US$ Million)

Figure 27. Asia-Pacific Sofosbuvir (CAS 1190307-88-0) Sales YoY (2017-2028) & (MT)

Figure 28. Asia-Pacific Sofosbuvir (CAS 1190307-88-0) Revenue YoY (2017-2028) & (US$ Million)

Figure 29. Latin America Sofosbuvir (CAS 1190307-88-0) Sales YoY (2017-2028) & (MT)

Figure 30. Latin America Sofosbuvir (CAS 1190307-88-0) Revenue YoY (2017-2028) & (US$ Million)

Figure 31. Middle East & Africa Sofosbuvir (CAS 1190307-88-0) Sales YoY (2017-2028) & (MT)

Figure 32. Middle East & Africa Sofosbuvir (CAS 1190307-88-0) Revenue YoY (2017-2028) & (US$ Million)

Figure 33. The Sofosbuvir (CAS 1190307-88-0) Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021

Figure 34. The Top 5 and 10 Largest Manufacturers of Sofosbuvir (CAS 1190307-88-0) in the World: Market Share by Sofosbuvir (CAS 1190307-88-0) Revenue in 2021

Figure 35. Sofosbuvir (CAS 1190307-88-0) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021

Figure 36. Global Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Type (2017-2028)

Figure 37. Global Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Type (2017-2028)

Figure 38. Global Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Application (2017-2028)

Figure 39. Global Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Application (2017-2028)

Figure 40. North America Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Type (2017-2028)

Figure 41. North America Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Type (2017-2028)

Figure 42. North America Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Application (2017-2028)

Figure 43. North America Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Application (2017-2028)

Figure 44. North America Sofosbuvir (CAS 1190307-88-0) Sales Share by Country (2017-2028)

Figure 45. North America Sofosbuvir (CAS 1190307-88-0) Revenue Share by Country (2017-2028)

Figure 46. U.S. Sofosbuvir (CAS 1190307-88-0) Revenue (2017-2028) & (US$ Million)

Figure 47. Canada Sofosbuvir (CAS 1190307-88-0) Revenue (2017-2028) & (US$ Million)

Figure 48. Europe Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Type (2017-2028)

Figure 49. Europe Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Type (2017-2028)

Figure 50. Europe Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Application (2017-2028)

Figure 51. Europe Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Application (2017-2028)

Figure 52. Europe Sofosbuvir (CAS 1190307-88-0) Sales Share by Country (2017-2028)

Figure 53. Europe Sofosbuvir (CAS 1190307-88-0) Revenue Share by Country (2017-2028)

Figure 54. Germany Sofosbuvir (CAS 1190307-88-0) Revenue (2017-2028) & (US$ Million)

Figure 55. France Sofosbuvir (CAS 1190307-88-0) Revenue (2017-2028) & (US$ Million)

Figure 56. U.K. Sofosbuvir (CAS 1190307-88-0) Revenue (2017-2028) & (US$ Million)

Figure 57. Italy Sofosbuvir (CAS 1190307-88-0) Revenue (2017-2028) & (US$ Million)

Figure 58. Russia Sofosbuvir (CAS 1190307-88-0) Revenue (2017-2028) & (US$ Million)

Figure 59. Asia Pacific Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Type (2017-2028)

Figure 60. Asia Pacific Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Type (2017-2028)

Figure 61. Asia Pacific Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Application (2017-2028)

Figure 62. Asia Pacific Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Application (2017-2028)

Figure 63. Asia Pacific Sofosbuvir (CAS 1190307-88-0) Sales Share by Region (2017-2028)

Figure 64. Asia Pacific Sofosbuvir (CAS 1190307-88-0) Revenue Share by Region (2017-2028)

Figure 65. China Sofosbuvir (CAS 1190307-88-0) Revenue (2017-2028) & (US$ Million)

Figure 66. Japan Sofosbuvir (CAS 1190307-88-0) Revenue (2017-2028) & (US$ Million)

Figure 67. South Korea Sofosbuvir (CAS 1190307-88-0) Revenue (2017-2028) & (US$ Million)

Figure 68. India Sofosbuvir (CAS 1190307-88-0) Revenue (2017-2028) & (US$ Million)

Figure 69. Australia Sofosbuvir (CAS 1190307-88-0) Revenue (2017-2028) & (US$ Million)

Figure 70. Taiwan Sofosbuvir (CAS 1190307-88-0) Revenue (2017-2028) & (US$ Million)

Figure 71. Indonesia Sofosbuvir (CAS 1190307-88-0) Revenue (2017-2028) & (US$ Million)

Figure 72. Thailand Sofosbuvir (CAS 1190307-88-0) Revenue (2017-2028) & (US$ Million)

Figure 73. Malaysia Sofosbuvir (CAS 1190307-88-0) Revenue (2017-2028) & (US$ Million)

Figure 74. Philippines Sofosbuvir (CAS 1190307-88-0) Revenue (2017-2028) & (US$ Million)

Figure 75. Latin America Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Type (2017-2028)

Figure 76. Latin America Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Type (2017-2028)

Figure 77. Latin America Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Application (2017-2028)

Figure 78. Latin America Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Application (2017-2028)

Figure 79. Latin America Sofosbuvir (CAS 1190307-88-0) Sales Share by Country (2017-2028)

Figure 80. Latin America Sofosbuvir (CAS 1190307-88-0) Revenue Share by Country (2017-2028)

Figure 81. Mexico Sofosbuvir (CAS 1190307-88-0) Revenue (2017-2028) & (US$ Million)

Figure 82. Brazil Sofosbuvir (CAS 1190307-88-0) Revenue (2017-2028) & (US$ Million)

Figure 83. Argentina Sofosbuvir (CAS 1190307-88-0) Revenue (2017-2028) & (US$ Million)

Figure 84. Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Type (2017-2028)

Figure 85. Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Type (2017-2028)

Figure 86. Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Application (2017-2028)

Figure 87. Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Application (2017-2028)

Figure 88. Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Sales Share by Country (2017-2028)

Figure 89. Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Revenue Share by Country (2017-2028)

Figure 90. Turkey Sofosbuvir (CAS 1190307-88-0) Revenue (2017-2028) & (US$ Million)

Figure 91. Saudi Arabia Sofosbuvir (CAS 1190307-88-0) Revenue (2017-2028) & (US$ Million)

Figure 92. U.A.E Sofosbuvir (CAS 1190307-88-0) Revenue (2017-2028) & (US$ Million)

Figure 93. Sofosbuvir (CAS 1190307-88-0) Value Chain

Figure 94. Sofosbuvir (CAS 1190307-88-0) Production Process

Figure 95. Channels of Distribution

Figure 96. Distributors Profiles

Figure 97. Bottom-up and Top-down Approaches for This Report

Figure 98. Data Triangulation

Figure 99. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (10% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Sofosbuvir (CAS 1190307-88-0) Market Insights, Forecast to 2028

Published Date: April 2022

Report Code: QYRE-Auto-21X7415

Global Sofosbuvir (CAS 1190307-88-0) Market Insights, Forecast to 2028

FEATURED COMPANIES

Segment by Type

Segment by Application

BY COMPANY

Production by Region

Consumption by Region

FEATURED COMPANIES

FEATURED COMPANIES

HAVE A QUERY?

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-19T20220

Wed Dec 03 00:00:00 UTC 2025

120 Pages

Type: Report

Code: QYRE-Auto-33H20007

Wed Dec 03 00:00:00 UTC 2025

120 Pages

Type: Report

Code: QYRE-Auto-5Y6896

Wed Dec 03 00:00:00 UTC 2025

120 Pages

Type: Report

Code: QYRE-Auto-10G20315

Wed Dec 03 00:00:00 UTC 2025

Support Contacts

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

POLICIES

THE COMPANY

CUSTOMER SUPPORT

OUR PRODUCTS

POLICES

Copyright © 2018 Valuates.com. All Rights Reserved.

Sitemap - Privacy Policy - Terms & Conditions